Bright Light Therapy Effective for Nonseasonal Depressive Disorders
By Elana Gotkine HealthDay Reporter
FRIDAY, Oct. 4, 2024 -- Bright light therapy (BLT) is an effective adjunctive treatment for nonseasonal depressive disorder, according to a review published online Oct. 2 in JAMA Psychiatry.
Artur Menegaz de Almeida, from the Federal University of Mato Grosso in Sinop, Brazil, and colleagues conducted a systematic review and meta-analysis to examine the effectiveness of BLT as an adjunctive treatment for nonseasonal depressive disorders. Eleven unique trials were included, with data from 858 patients (75.6 percent females).
The researchers found that the BLT group had significantly better remission and response rates (remission: 40.7 versus 23.5 percent [odds ratio, 2.42]; response: 60.4 versus 38.6 percent [odds ratio, 2.34]). Subgroup analysis based on follow-up times also showed better remission and response with BLT (remission: less than four weeks, 27.4 versus 9.2 [odds ratio, 3.59]; more than four weeks, 46.6 versus 29.1 percent [odds ratio, 2.18]; response: less than four weeks, 55.6 versus 27.4 percent [odds ratio, 3.65]; more than four weeks, 63.0 versus 44.9 percent [odds ratio, 1.79]).
"Our study results suggest that BLT offers significant benefits as an adjunctive treatment for these conditions," the authors write. "In addition, different follow-up times assessed in the subgroup analysis suggest that BLT not only increases remission and response rates but also accelerates the time to respond to initial treatment."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Chronic Exposure to Systemic Inflammation May Increase Risk for Affective Disorders
THURSDAY, July 3, 2025 -- For individuals with specific autoimmune conditions, there appears to be an increased risk for affective disorders, according to a study published online...
Late-Life Mood Disorders May Indicate Predisposition to Dementia
MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study published online June 9...
Addictive Screen Use Tied to Suicidal Behaviors in Early Adolescence
FRIDAY, June 27, 2025 -- Both high and increasing addictive screen use trajectories are associated with suicidal behaviors and worse mental health in early adolescence, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.